Hypertension Clinical Trial
Official title:
Improving Care Transitions for Complex Patients Through Decision Support
Verified date | February 2014 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to improve patient care and safety while decreasing ED visit
rates by sending specific information about care transitions related to hospital admission
and discharge and emergency department and specialty care visits to primary care practices,
care managers and patients with the use of health information technology (HIT) shared across
a community-based network of providers.
Cycle 1 focuses on the impact of notices about ED encounters and hospitalizations derived
from billing data that are sent to care managers for all 47,000 patients in the Northern
Piedmont Community Care Network (NPCCN). Cycle 2 explores the impact of letters sent to
patients, and care event reports sent to a patient's medical home in addition to notices
sent to care managers about ED encounters, hospitalization and specialty care based on ADT
(Admission Discharge Transfer) and billing data on 4,600 patients with complex health needs.
Status | Completed |
Enrollment | 8422 |
Est. completion date | September 2012 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - North Carolina Medicaid beneficiary enrolled in the Northern Piedmont Community Care Network (NPCCN) - Has complex healthcare needs as defined by having two or more IOM (Institute of Medicine) priority conditions (hypertension, coronary artery disease, congestive heart failure, stroke, asthma, diabetes) OR one of the following: moderate to severe mental health diagnosis (schizophrenic disorder, episodic mood disorder, delusional disorder, non-organic psychosis, anxiety, dissociative-somatoform disorder, personality disorder), end-stage renal disease, sickle cell disease - Continuous enrollment in NPCCN for 10 of the previous 12 months |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Duke University Medical Center (Division of Clinical Informatics) | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University | North Carolina Division of Medical Assistance, Northern Piedmont Carolina Community Care Partners |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Emergency department encounter rates among patients in the study population. | 6 months | No | |
Secondary | Emergency department encounter rates for low severity diagnoses among all patients. | 6 months | No | |
Secondary | Total emergency department encounter rates among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Total emergency department encounter rates among all patients. | 6 months | No | |
Secondary | Hospitalization rates among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Hospitalization rates among all patients. | 6 months | No | |
Secondary | Hospital readmission rates within 30 days after hospitalization among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Hospital readmission rates within 30 days after hospitalization among all patients. | 6 months | No | |
Secondary | Primary care visit rates among patients following an emergency department encounter or hospitalization for whom intervention was appropriate. | 6 months | No | |
Secondary | Primary care visit rates among all patients following an emergency department encounter or hospitalization. | 6 months | No | |
Secondary | Rates of completion of medically-indicated post hospitalization studies or procedures among patients for whom intervention was appropriate. | 6 months | Yes | |
Secondary | Rates of completion of medically-indicated post hospitalization studies or procedures among all patients. | 6 months | Yes | |
Secondary | Total medical costs among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Total medical costs among all patients. | 6 months | No | |
Secondary | Emergency department costs among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Emergency department costs among all patients. | 6 months | No | |
Secondary | Hospitalization costs among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Hospitalization costs among all patients. | 6 months | No | |
Secondary | Outpatient costs among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Outpatient costs among all patients. | 6 months | No | |
Secondary | Patient satisfaction among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Patient-reported quality of life among patients for whom intervention was appropriate. | 6 months | No | |
Secondary | Provider satisfaction among providers with contact with patients for whom intervention was appropriate. | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |